228 related articles for article (PubMed ID: 34248927)
1. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report.
Pollack S; Eisenstein I; Mory A; Paperna T; Ofir A; Baris-Feldman H; Weiss K; Veszeli N; Csuka D; Shemer R; Glaser F; Prohászka Z; Magen D
Front Immunol; 2021; 12():608604. PubMed ID: 34248927
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.
Mele C; Lemaire M; Iatropoulos P; Piras R; Bresin E; Bettoni S; Bick D; Helbling D; Veith R; Valoti E; Donadelli R; Murer L; Neunhäuserer M; Breno M; Frémeaux-Bacchi V; Lifton R; Remuzzi G; Noris M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1011-9. PubMed ID: 25854283
[TBL] [Abstract][Full Text] [Related]
3. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report.
Alabdulqader M; Alfakeeh K
BMC Nephrol; 2021 Apr; 22(1):140. PubMed ID: 33879077
[TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome.
Gholizad-Kolveiri S; Hooman N; Alizadeh R; Hoseini R; Otukesh H; Talebi S; Akouchekian M
BMC Med Genet; 2020 Aug; 21(1):169. PubMed ID: 32838746
[TBL] [Abstract][Full Text] [Related]
5. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
6. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
[TBL] [Abstract][Full Text] [Related]
7. Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy.
Haydock L; Garneau AP; Tremblay L; Yen HY; Gao H; Harrisson R; Isenring P
J Mol Med (Berl); 2022 Feb; 100(2):269-284. PubMed ID: 34714369
[TBL] [Abstract][Full Text] [Related]
8. Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice.
Smith-Jackson K; Yang Y; Denton H; Pappworth IY; Cooke K; Barlow PN; Atkinson JP; Liszewski MK; Pickering MC; Kavanagh D; Cook HT; Marchbank KJ
J Clin Invest; 2019 Mar; 129(3):1061-1075. PubMed ID: 30714990
[TBL] [Abstract][Full Text] [Related]
9. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.
Siomou E; Gkoutsias A; Serbis A; Kollios K; Chaliasos N; Frémeaux-Bacchi V
Pediatr Nephrol; 2016 Mar; 31(3):513-7. PubMed ID: 26572892
[TBL] [Abstract][Full Text] [Related]
10. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.
Yoshida Y; Miyata T; Matsumoto M; Shirotani-Ikejima H; Uchida Y; Ohyama Y; Kokubo T; Fujimura Y
PLoS One; 2015; 10(5):e0124655. PubMed ID: 25951460
[TBL] [Abstract][Full Text] [Related]
11. Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Perkins SJ
Adv Chronic Kidney Dis; 2020 Mar; 27(2):120-127.e4. PubMed ID: 32553244
[TBL] [Abstract][Full Text] [Related]
12. Atypical hemolytic uremic syndrome.
Loirat C; Frémeaux-Bacchi V
Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
[TBL] [Abstract][Full Text] [Related]
13. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
Walsh PR; Johnson S; Brocklebank V; Salvatore J; Christian M; Kavanagh D
Am J Kidney Dis; 2018 Feb; 71(2):287-290. PubMed ID: 29248304
[TBL] [Abstract][Full Text] [Related]
14. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report.
Osawa K; Yamamoto S; Yamano Y; Kita A; Okamoto K; Kato N; Tatematsu Y; Kojima F; Ohya M; Hara S; Murata SI; Inoue N; Maruyama S; Araki SI
Intern Med; 2024 Jun; 63(12):1777-1782. PubMed ID: 37926536
[TBL] [Abstract][Full Text] [Related]
15. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.
Matsumoto T; Fan X; Ishikawa E; Ito M; Amano K; Toyoda H; Komada Y; Ohishi K; Katayama N; Yoshida Y; Matsumoto M; Fujimura Y; Ikejiri M; Wada H; Miyata T
Int J Hematol; 2014 Nov; 100(5):437-42. PubMed ID: 25135378
[TBL] [Abstract][Full Text] [Related]
16. Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.
Toyoda H; Wada H; Miyata T; Amano K; Kihira K; Iwamoto S; Hirayama M; Komada Y
J Pediatr Hematol Oncol; 2016 Apr; 38(3):e137-9. PubMed ID: 26840081
[TBL] [Abstract][Full Text] [Related]
17. Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome.
Aradottir SS; Kristoffersson AC; Linnér E; Karpman D
Pediatr Nephrol; 2024 Apr; 39(4):1105-1111. PubMed ID: 37955705
[TBL] [Abstract][Full Text] [Related]
18. Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.
Sánchez Chinchilla D; Pinto S; Hoppe B; Adragna M; Lopez L; Justa Roldan ML; Peña A; Lopez Trascasa M; Sánchez-Corral P; Rodríguez de Córdoba S
Clin J Am Soc Nephrol; 2014 Sep; 9(9):1611-9. PubMed ID: 25135762
[TBL] [Abstract][Full Text] [Related]
19. The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report.
Lumbreras J; Subias M; Espinosa N; Ferrer JM; Arjona E; Rodríguez de Córdoba S
Front Immunol; 2020; 11():1348. PubMed ID: 32765494
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
